Literature DB >> 12438920

Levels of beta-secretase BACE and alpha-secretase ADAM10 mRNAs in Alzheimer hippocampus.

Luisa Benerini Gatta1, Alberto Albertini, Rivka Ravid, Dario Finazzi.   

Abstract

The amyloid cascade hypothesis suggests that amyloid precursor protein (APP) proteolytic processing is a key event in the pathogenesis of Alzheimer's disease (AD). The enzymes beta-site APP cleaving enzyme (BACE) and A disintegrin and metalloproteinase 10 (ADAM10) play an important role in APP proteolysis. We measured by real time quantitative polymerase chain reaction their mRNA levels in hippocampal and cerebellar sections from 13 AD and 12 control brains. BACE mRNA amounts were similar in patients and controls. In contrast, ADAM10 mRNA levels were twofold higher in AD samples, but without relationship to the severity of anatomical damage. The data do not support the hypothesis that alteration of BACE and ADAM10 expression are associated with development of late stages of AD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12438920     DOI: 10.1097/00001756-200211150-00008

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  24 in total

Review 1.  Regulation of α-secretase ADAM10 expression and activity.

Authors:  Kristina Endres; Falk Fahrenholz
Journal:  Exp Brain Res       Date:  2011-10-04       Impact factor: 1.972

2.  Effect of ischemic neuronal insults on amyloid precursor protein processing.

Authors:  Phil Hyu Lee; Eun Mi Hwang; Hyun Seok Hong; Jung Hyun Boo; Inhee Mook-Jung; Kyoon Huh
Journal:  Neurochem Res       Date:  2006-06-21       Impact factor: 3.996

3.  Effects of aging, dietary restriction and glucocorticoid treatment on housekeeping gene expression in rat cortex and hippocampus-evaluation by real time RT-PCR.

Authors:  Nikola Tanic; Milka Perovic; Aleksandra Mladenovic; Sabera Ruzdijic; Selma Kanazir
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

4.  Association of ADAM10 and CAMK2A polymorphisms with conduct disorder: evidence from family-based studies.

Authors:  Xue-Qiu Jian; Ke-Sheng Wang; Tie-Jian Wu; Joel J Hillhouse; Jerald E Mullersman
Journal:  J Abnorm Child Psychol       Date:  2011-08

5.  Expression of the anti-amyloidogenic secretase ADAM10 is suppressed by its 5'-untranslated region.

Authors:  Sven Lammich; Dominik Buell; Sonja Zilow; Ann-Katrin Ludwig; Brigitte Nuscher; Stefan F Lichtenthaler; Claudia Prinzen; Falk Fahrenholz; Christian Haass
Journal:  J Biol Chem       Date:  2010-03-26       Impact factor: 5.157

6.  The Transcriptional Regulatory Properties of Amyloid Beta 1-42 may Include Regulation of Genes Related to Neurodegeneration.

Authors:  Duygu Gezen-Ak; İrem L Atasoy; Esin Candaş; Merve Alaylıoğlu; Erdinç Dursun
Journal:  Neuromolecular Med       Date:  2018-06-12       Impact factor: 3.843

7.  CA1 pyramidal neuron gene expression mosaics in the Ts65Dn murine model of Down syndrome and Alzheimer's disease following maternal choline supplementation.

Authors:  Melissa J Alldred; Helen M Chao; Sang Han Lee; Judah Beilin; Brian E Powers; Eva Petkova; Barbara J Strupp; Stephen D Ginsberg
Journal:  Hippocampus       Date:  2018-02-12       Impact factor: 3.899

8.  MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1.

Authors:  Vincent Boissonneault; Isabelle Plante; Serge Rivest; Patrick Provost
Journal:  J Biol Chem       Date:  2008-11-05       Impact factor: 5.157

Review 9.  Pathophysiological Function of ADAMTS Enzymes on Molecular Mechanism of Alzheimer's Disease.

Authors:  Murat Serdar Gurses; Mustafa Numan Ural; Mehmet Akif Gulec; Omer Akyol; Sumeyya Akyol
Journal:  Aging Dis       Date:  2016-01-11       Impact factor: 6.745

Review 10.  BACE and gamma-secretase characterization and their sorting as therapeutic targets to reduce amyloidogenesis.

Authors:  Neville Marks; Martin J Berg
Journal:  Neurochem Res       Date:  2009-09-17       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.